UNSPSC 51283728: Loracarbef monohydrate

This classification denotes a cephalosporin antibiotic with the molecular formula C16H16ClN3O4.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3X11EVM5SU, chemically known as 1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((aminophenylacetyl)amino)-3-chloro-8-oxo-, monohydrate, (6r-(6.alpha.,7.beta.(r*)))-, but more generally known as loracarbef monohydrate, which bears US NIH Compound Identifier 60746.

European Medicines Agency schedules loracarbef monohydrate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08578MIG. Most nations, for tariff purposes, schedule loracarbef monohydrate under HS 29419000. SMILES: C1CCC(CC1)[C@H](C(=O)N[C@H]2[C@H]3CCC(=C(N3C2=O)C(=O)O)CL)N.O.

UNSPSC 51283728 Loracarbef monohydrate is a Commodity code that covers specific pharmaceutical products procured by state and local health authorities. Recent opportunities under this code show little activity directly aligned with loracarbef monohydrate itself; instead, state and local issuing bodies are soliciting related pharmaceutical inventory and medical supply contracts through piggyback and cooperative purchasing vehicles. The Illinois Department of Public Health awarded a pharmaceutical warehouse piggyback contract through the MMCAP Infuse consortium for antibiotic tablets (Doxycycline Hyclate and Ciprofloxacin Hydrochloride), while Seminole County, Florida sought Naloxone and Safe Drug Deactivation Systems through competitive bidding. These procurements reflect state health departments and county public health authorities using cooperative purchasing and IFB processes to supply pharmaceutical and medical products to community health facilities on recurring annual or multi-year terms.

Recent activity under the code shows procurement spread across Florida and Illinois, with health departments and county health authorities as the primary issuing bodies. The Illinois Department of Public Health's August 2026 award to Chartwell Rx LLC covered a $2,999,999.11 three-year pharmaceutical contract through the MMCAP Infuse consortium, while Seminole County's June 2026 IFB for Naloxone and drug deactivation systems (due July 26, 2023) required quarterly deliveries to the Seminole County Community Health Building in Sanford with initial two-year contract terms and renewal options. Note that the code shows limited recent opportunities directly matching loracarbef monohydrate procurement; the tagged opportunities involve related but distinct pharmaceutical product lines, suggesting the code may see infrequent activity or tagging misalignment with actual state and local buying patterns for this specific antibiotic.